Your email has been successfully added to our mailing list.

×
0 -0.00375939849624065 -0.0417593984962406 -0.0165413533834587 -0.0977443609022557 -0.0714285714285714 -0.0654135338345865 -0.0669172932330828
Stock impact report

Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update on License and Collaboration Agreement with Neurocrine Biosciences [Canadian Business Journal (Canada)...

Xenon Pharmaceuticals, Inc (XENE)  More Company Research Source: Canadian Business Journal
Last xenon pharmaceuticals, inc earnings: 11/5 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.xenon-pharma.com
PDF Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update on License and Collaboration Agreement with Neurocrine Biosciences, The Canadian Business Journal Send to Email Address Your Name Your Email Address Cancel Post was not sent - check your email addresses! Email check failed, please try again Sorry, your blog cannot share posts by email. [Read more]
Impact snapshot Event time: XENE
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
XENE alerts
from News Quantified
Opt-in for
XENE alerts

from News Quantified
Opt-in for
XENE alerts

from News Quantified